BG
MYOK

BlackRock Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

BlackRock Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$32K Buy
+2,503
New +$38.6K ﹤0.01% 2943

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BlackRock Group's MYOK Position: Q4 2016 in Review

BlackRock Group opened a new position in MyoKardia, Inc. Common Stock (MYOK) in Q4 2016: 2,503 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2943 among its holdings.

71 funds tracked by Wall St. Rank hold MYOK as of Q4 2016.

  • BlackRock Group held 2,503 shares of MyoKardia, Inc. Common Stock worth $32K as of Q4 2016.
  • MyoKardia, Inc. Common Stock was a new BlackRock Group position in Q4 2016.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2943 holding.
  • 71 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.